Literature DB >> 22714759

Actinic keratosis: a clinical and epidemiological revision.

Juliano Vilaverde Schmitt1, Hélio Amante Miot.   

Abstract

Actinic keratoses are benign intraepithelial skin neoplasms constituted by atypical proliferation of keratinocytes that may evolve to squamous cell carcinoma. They develop in photoexposed skin areas; they are induced mainly by ultraviolet radiation and are considered cutaneous markers of chronic exposure to sunlight. They develop mainly in adults and older, fair skinned individuals, and are the fourth most common cause of dermatologic consultation in Brazil. Damage to the apoptosis pathway in photoexposed epithelium favors cellular proliferation and the permanence of the lesions. In this revision, the authors assemble the main epidemiological data regarding this disease and suggest that strategies to identify risky phenotypes, early diagnosis, adequate treatment, clinical follow-up, stimulus to skin self examination, photoeducation and photoprotection should be promoted with the aim of avoiding the progression to malignancy and also the prevention and the diagnose of concomitant neoplasms also induced by ultraviolet radiation.

Entities:  

Mesh:

Year:  2012        PMID: 22714759     DOI: 10.1590/s0365-05962012000300012

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  22 in total

1.  The Mast Cell-SCF-CB1 Interaction Is a Key Player in Seborrheic Keratosis.

Authors:  Mika Yamanaka-Takaichi; Koji Sugawara; Rieko Sumitomo; Daisuke Tsuruta
Journal:  J Histochem Cytochem       Date:  2020-06-24       Impact factor: 2.479

2.  Cultural adaptation and validation of the quality of life questionnaire for patients with actinic keratosis (AKQoL-BR) to Brazilian Portuguese.

Authors:  Marcella Akemi Haruno de Vilhena; Ivanka Miranda de Castro; Anna Carolina Miola; Ingrid Stresser Gioppo; Amanda Soares Teixeira; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2022-09-20       Impact factor: 2.113

Review 3.  [Skin diseases in geriatric patients. Epidemiologic data].

Authors:  E Makrantonaki; A I Liakou; R Eckardt; M Zens; E Steinhagen-Thiessen; C C Zouboulis
Journal:  Hautarzt       Date:  2012-12       Impact factor: 0.751

Review 4.  Retinoids for prevention and treatment of actinic keratosis.

Authors:  Mayra Ianhez; Luiz Fernando Fróes Fleury; Hélio Amante Miot; Edileia Bagatin
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

5.  Noninvasive Long-term Monitoring of Actinic Keratosis and Field Cancerization Following Treatment with Ingenol Mebutate Gel 0.015.

Authors:  Orit Markowitz; Katie Wang; Amanda Levine; Michelle Schwartz; Sumeet Minhas; Eleanor Feldman; Daniel M Siegel
Journal:  J Clin Aesthet Dermatol       Date:  2017-10-01

Review 6.  Reviewing Challenges in the Diagnosis and Treatment of Lentigo Maligna and Lentigo-Maligna Melanoma.

Authors:  Margit L W Juhász; Ellen S Marmur
Journal:  Rare Cancers Ther       Date:  2015-10-15

7.  Extrinsic aging: UV-mediated skin carcinogenesis.

Authors:  Fragkiski Tsatsou; Myrto Trakatelli; Aikaterini Patsatsi; Konstantinos Kalokasidis; Dimitrios Sotiriadis
Journal:  Dermatoendocrinol       Date:  2012-07-01

8.  Primary care review of actinic keratosis and its therapeutic options: a global perspective.

Authors:  Praven Chetty; Felix Choi; Timothy Mitchell
Journal:  Dermatol Ther (Heidelb)       Date:  2015-02-03

9.  Invasive head and neck cutaneous squamous cell carcinoma: clinical and histopathological characteristics, frequency of local recurrence and metastasis.

Authors:  Luiza Vasconcelos; Juliana Carneiro Melo; Hélio Amante Miot; Mariângela Esther Alencar Marques; Luciana Patricia Fernandes Abbade
Journal:  An Bras Dermatol       Date:  2014 Jul-Aug       Impact factor: 1.896

Review 10.  A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.

Authors:  Robert Sinclair; Christopher Baker; Lynda Spelman; Madeleine Supranowicz; Beth MacMahon
Journal:  Australas J Dermatol       Date:  2020-08-25       Impact factor: 2.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.